资讯
17 小时on MSN
US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Changes to Medicaid could leave thousands of South Dakotans uninsured and impair an already fragile rural health care system, ...
The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...
For two decades, Washington, D.C., pediatrician Lanre Falusi has counseled parents about vaccine safety, side effects, and ...
U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
23 小时
Free Malaysia Today on MSNUS plans Medicare, Medicaid coverage for weight-loss drugs
WASHINGTON: The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the ...
The Trump administration is exploring a five-year pilot program to include weight-loss drugs like Wegovy, Ozempic, Zepbound, ...
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果